Markus is the Executive Vice President, Business Development, for GE Healthcare. He is responsible for developing the GE Healthcare growth strategy, and identifying and executing mergers and acquisitions, investments, licenses, and alliances in support of the strategic growth initiatives of the business.

Prior to joining GE in September 2011, Markus was Head of Strategy, BD&L, and M&A for Novartis Molecular Diagnostics, and served as a member of the leadership team. In mid-2005, Markus joined Novartis in Basel, Switzerland as a member of the Cardiovascular & Metabolism Franchise Board for Novartis Pharma AG and the Global Business Development & Licensing group where he was responsible for acquiring and licensing projects for the Franchise.

From 1998 to 2005, Markus was President & CEO of two biotech start-ups, initially Axxima Pharmaceuticals AG (focusing on infectious diseases) and subsequently Xerion Pharmaceuticals AG (focusing on mAb technologies and research for cancer therapeutics), both based in Munich, Germany.

Between 1995 and 1998, Markus was the head of International Product Management at Schwarz Pharma where he was later named Director of Business and Corporate Development. At Schwarz, he launched two international core brands and orchestrated several key business transactions.

In 1993, Markus joined The Boston Consulting Group in Munich as consultant to pharmaceutical and chemical companies.

Markus holds a PhD in molecular biology from the University of Heidelberg and an MBA from the University of Chicago